Press Releases
- European regulatory approval obtained to resume enrolment in the HOVON 172 MF study evaluating tasquinimod in myelofibrosis and conducted in collaboration between Active Biotech, Oncode and HOVON
- Active Biotech Interim Report Q1 2026
- Active Biotech publishes results from the LION study on ocular absorption and distribution of laquinimod in the eye
- NOTICE OF ANNUAL GENERAL MEETING
- Annual Report 2025 Active Biotech AB (publ)